Porter Stacey L. 4
4 · Outset Medical, Inc. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
Porter Stacey L.
Chief People Officer
Transactions
- Sale
Common Stock
2024-01-16$4.29/sh−768$3,295→ 61,448 total - Award
Common Stock
2024-01-12+3,586→ 62,216 total
Footnotes (2)
- [F1]On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date.
- [F2]Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (1) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.